A cautionary tale that Europe can’t afford to ignore
It’s a problem that has plagued European governments for decades, from the credit-crunch bank bailouts of 2008 to more recent ...
Novo Nordisk A/S (NVO): A Bull Case Theory
We came across a bullish thesis on Novo Nordisk A/S (NVO) on Long-Term Pick’s Substack by Dan. In this article, we will summarize the bulls’ thesis on NVO.
Novo Nordisk hits $500 billion in market value as it flags soaring demand for Wegovy, Ozempic
Novo Nordisk on Wednesday reported better ... and diabetes drugs continued to soar. The maker of weight loss drug Wegovy and ...
Billionaire Philippe Laffont Just Sold Top Artificial Intelligence Stocks Nvidia and AMD and Piled Into 2 Players Dominating Another High-Growth Billion-Dollar Industry
As founder of Coatue Management, Philippe Laffont oversees $26.9 billion invested in more than 80 stocks, and though he buys ...
unilad23h
People are just starting to complain about unexpected side-effect known as 'Ozempic butt'
People who have been using Ozempic have been complaining of a bizarre side-effect, which has been nicknamed 'Ozempic butt'.
Livewire Markets on MSN13h
ResMed's latest earnings are "super impressive", says this fund manager
Although RMD has re-rated from its share price low of around $21.50 in October 2023, it has only just surpassed its all-time ...
About half of Americans approve of using weight-loss drugs to treat obesity, AP-NORC poll finds
A new poll from The Associated Press-NORC Center for Public Affairs Research shows about half of U.S. adults believe it is a good thing for adults to use weight-loss drugs like Ozempic, Wegovy and ...